SCHEMBL6164547

SCHEMBL6164547

CC(C)c1nn(-c2ccccc2)c2c1C(=O)CC(C(C)C)C2

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.43
BUB1 O43683 1/20 0.36
PDE4B Q07343 5/20 0.36
ALDH1A1 P00352 3/20 0.35
GAA P10253 1/20 0.35
BRD4 O60885 1/20 0.35
HIF1A Q16665 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
PDE5A O76074 2/20 0.34
PDE3A Q14432 2/20 0.34
TSHR P16473 2/20 0.34
HPGD P15428 1/20 0.34
RIPK1 Q13546 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6767785 0.89 L3MBTL1 (0.39) DHODHPDE4BALDH1A1SMN1; SMN2MEN1
SCHEMBL6769804 0.88 PPARA (0.38) DHODHBUB1PDE4B
SCHEMBL6767259 0.87 SRC (0.40) DHODHALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL6167296 0.86 HIF1A (0.47) DHODHALDH1A1BRD4HIF1ASMN1; SMN2
SCHEMBL6164455 0.86 ABCG2 (0.47) BUB1PDE4BALDH1A1GAAHIF1A
SCHEMBL6777339 0.85 CASP1 (0.39) DHODHALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL6168419 0.84 DHODH (0.42) DHODHBUB1ALDH1A1GAABRD4
SCHEMBL6163901 0.83 SMN1; SMN2 (0.46) DHODHBUB1ALDH1A1SMN1; SMN2CCNA2
SCHEMBL6164978 0.82 DHODH (0.41) DHODHBUB1ALDH1A1GAABRD4
SCHEMBL6162163 0.81 DHODH (0.41) DHODHBUB1ALDH1A1BRD4HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed